Jefferies, a global investment bank, has released its latest report on the Contract Research and Development Manufacturing Organization (CRDMO) sector. The report highlights top picks and revises target prices for several key players in the industry. <\/p>\n
Sai Life Sciences and Divi’s Labs have emerged as Jefferies’ top picks in the CRDMO sector. Sai Life Sciences, a leading player in the sector, has seen significant growth in recent times due to its strong capabilities in research and development, as well as its expanding customer base. Divi’s Labs, another major player, has also been performing well due to its diversified product portfolio and strong manufacturing capabilities. <\/p>\n
On the other hand, Jefferies has cut the target price for Piramal Pharma and Cohance. Piramal Pharma, a global pharmaceutical company, has faced challenges in recent times due to increased competition and regulatory hurdles. Despite this, the company remains a significant player in the CRDMO sector due to its strong research and development capabilities and diversified product portfolio. <\/p>\n
Cohance, another major player in the sector, has also seen a reduction in its target price. The company has faced challenges in recent times due to increased competition and pricing pressure. However, Cohance remains a significant player in the CRDMO sector due to its strong manufacturing capabilities and expanding customer base. <\/p>\n
The revision in target prices by Jefferies reflects the changing dynamics of the CRDMO sector. The sector has seen significant growth in recent times due to increasing demand for outsourced research and development, as well as manufacturing services. However, the sector is also facing challenges due to increased competition, regulatory hurdles, and pricing pressure. <\/p>\n
Overall, Jefferies’ report highlights the opportunities and challenges in the CRDMO sector. The report emphasizes the need for companies to have strong research and development capabilities, diversified product portfolios, and strong manufacturing capabilities to remain competitive in the sector. Sai Life Sciences and Divi’s Labs have emerged as top picks due to their strong capabilities in these areas, while Piramal Pharma and Cohance have seen a reduction in their target prices due to challenges in these areas. <\/p>\n
The report also highlights the importance of regulatory compliance and pricing strategy in the CRDMO sector. Companies that are able to navigate these challenges effectively are likely to remain competitive and achieve significant growth in the sector. As the CRDMO sector continues to evolve, it is likely that we will see further changes in the target prices of key players in the sector.<\/p>\n","protected":false},"excerpt":{"rendered":"
Jefferies, a global investment bank, has released its latest report on the Contract Research and Development Manufacturing Organization (CRDMO) sector. The report highlights top picks and revises target prices for several key players in the industry. Sai Life Sciences and Divi’s Labs have emerged as Jefferies’ top picks in the CRDMO sector. Sai Life Sciences, […]<\/p>\n","protected":false},"author":1,"featured_media":88036,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-89777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-divis-laboratories"],"jetpack_featured_media_url":"https:\/\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89766,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/08\/anand-rathis-siddharth-sedani-reveals-his-top-4-stock-picks-do-they-feature-in-your-investment-portfolio\/","url_meta":{"origin":89777,"position":0},"title":"Anand Rathi’s Siddharth Sedani reveals his top 4 stock picks – do they feature in your investment portfolio?","author":"Team Small News","date":"January 8, 2026","format":false,"excerpt":"The Indian pharmaceutical sector is offering investors a chance to build a strong portfolio under the theme \"Ayush Kart\", as stated by Siddharth Sedani, Managing Director at Anand Rathi. The Indian pharma sector has been growing rapidly, and this trend is expected to continue, making it an attractive investment opportunity.\u2026","rel":"","context":"In "Divi's Laboratories"","block_context":{"text":"Divi's Laboratories","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/divis-laboratories\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89810,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/16\/will-indian-pharmaceuticals-domestic-offerings-provide-a-buffer-against-pricing-pressures-from-the-us-market-in-the-third-quarter\/","url_meta":{"origin":89777,"position":1},"title":"Will Indian pharmaceuticals’ domestic offerings provide a buffer against pricing pressures from the US market in the third quarter?","author":"Team Small News","date":"January 16, 2026","format":false,"excerpt":"The Indian pharmaceutical industry is expected to have a mixed third quarter, with domestic formulations and specialty launches driving growth despite US pricing pressure. Companies like Sun Pharmaceuticals and Lupin are likely to lead the way, driven by their specialty businesses. Sun Pharma's revenue is expected to grow in the\u2026","rel":"","context":"In "Divi's Laboratories"","block_context":{"text":"Divi's Laboratories","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/divis-laboratories\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89712,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/27\/glenmark-pharmaceuticals-usa-has-introduced-a-multiple-dose-vial-of-epinephrine-injection\/","url_meta":{"origin":89777,"position":2},"title":"Glenmark Pharmaceuticals USA has introduced a multiple-dose vial of epinephrine injection.","author":"Team Small News","date":"December 27, 2025","format":false,"excerpt":"Glenmark Pharmaceuticals Inc, USA, has launched Epinephrine Injection USP, a bioequivalent and therapeutically equivalent product to the reference listed drug manufactured by BPI Labs, LLC. The product is available in a 30 mg\/30 mL (1 mg\/mL) Multiple-Dose Vial and is intended for the U.S. market. According to IQVIA sales data,\u2026","rel":"","context":"In "Glenmark"","block_context":{"text":"Glenmark","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/glenmark\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89791,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/12\/aurobindo-pharma-acquires-khandelwal-labs-non-cancer-portfolio-for-%e2%82%b9325-crore\/","url_meta":{"origin":89777,"position":3},"title":"Aurobindo Pharma Acquires Khandelwal Labs’ Non-Cancer Portfolio for \u20b9325 Crore.","author":"Team Small News","date":"January 12, 2026","format":false,"excerpt":"Aurobindo Pharma, a leading Indian pharmaceutical company, has acquired the non-oncology business of Khandelwal Laboratories for \u20b9325 crore. The acquisition is a strategic move by Aurobindo Pharma to expand its product portfolio and strengthen its position in the domestic market. Khandelwal Laboratories is a Mumbai-based pharmaceutical company that operates in\u2026","rel":"","context":"In "Aurobindo Pharma"","block_context":{"text":"Aurobindo Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/aurobindo-pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89809,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/16\/indian-pharma-q3-preview-strong-domestic-formulations-segment-to-offset-us-pricing-challenges-scanx-trade\/","url_meta":{"origin":89777,"position":4},"title":"Indian Pharma Q3 Preview: Strong Domestic Formulations Segment to Offset US Pricing Challenges – scanx.trade","author":"Team Small News","date":"January 16, 2026","format":false,"excerpt":"The Indian pharmaceutical industry is expected to experience a mixed bag in the third quarter of the year, with domestic formulations likely to counterbalance the pressure from pricing in the US market. The sector's growth is anticipated to be driven by a strong performance in the domestic market, which is\u2026","rel":"","context":"In "Dr Reddy's"","block_context":{"text":"Dr Reddy's","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/dr-reddys\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":89755,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/05\/polypeptide-forms-partnership-with-lupin-speciality-chemicals-magazine\/","url_meta":{"origin":89777,"position":5},"title":"PolyPeptide forms partnership with Lupin | Speciality Chemicals Magazine","author":"Team Small News","date":"January 5, 2026","format":false,"excerpt":"PolyPeptide, a leading manufacturer of peptides, has formed a strategic alliance with Lupin Manufacturing Solutions. The partnership aims to establish a framework for long-term cooperation, focusing on integrated procurement and supply planning for select raw materials. This alliance will enable PolyPeptide to diversify its sourcing options for key materials, including\u2026","rel":"","context":"In "Lupin"","block_context":{"text":"Lupin","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/lupin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89777"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89777\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media\/88036"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}